About methyl 2-[6-[3-(1,3-thiazol-2-yl)piperidin-1-yl]pyrazin-2-yl]sulfanylacetate
methyl 2-[6-[3-(1,3-thiazol-2-yl)piperidin-1-yl]pyrazin-2-yl]sulfanylacetate (PubChem CID 133469455) has the molecular formula C15H18N4O2S2
and a molecular weight of 350.47 g/mol. Its IUPAC name is methyl 2-[6-[3-(1,3-thiazol-2-yl)piperidin-1-yl]pyrazin-2-yl]sulfanylacetate.
Analyze methyl 2-[6-[3-(1,3-thiazol-2-yl)piperidin-1-yl]pyrazin-2-yl]sulfanylacetate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of methyl 2-[6-[3-(1,3-thiazol-2-yl)piperidin-1-yl]pyrazin-2-yl]sulfanylacetate?
The IUPAC name of methyl 2-[6-[3-(1,3-thiazol-2-yl)piperidin-1-yl]pyrazin-2-yl]sulfanylacetate (CID 133469455) is methyl 2-[6-[3-(1,3-thiazol-2-yl)piperidin-1-yl]pyrazin-2-yl]sulfanylacetate.
What is the SMILES notation for methyl 2-[6-[3-(1,3-thiazol-2-yl)piperidin-1-yl]pyrazin-2-yl]sulfanylacetate?
The canonical SMILES for methyl 2-[6-[3-(1,3-thiazol-2-yl)piperidin-1-yl]pyrazin-2-yl]sulfanylacetate is COC(=O)CSc1cncc(N2CCCC(c3nccs3)C2)n1.
What is the InChIKey of methyl 2-[6-[3-(1,3-thiazol-2-yl)piperidin-1-yl]pyrazin-2-yl]sulfanylacetate?
The InChIKey is GLIJLIKDCKAMAT-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H18N4O2S2/c1-21-14(20)10-23-13-8-16-7-12(18-13)19-5-2-3-11(9-19)15-17-4-6-22-15/h4,6-8,11H,2-3,5,9-10H2,1H3.
What are the key properties of methyl 2-[6-[3-(1,3-thiazol-2-yl)piperidin-1-yl]pyrazin-2-yl]sulfanylacetate?
methyl 2-[6-[3-(1,3-thiazol-2-yl)piperidin-1-yl]pyrazin-2-yl]sulfanylacetate has a molecular weight of 350.47 g/mol, XLogP of 2.58, 5 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for methyl 2-[6-[3-(1,3-thiazol-2-yl)piperidin-1-yl]pyrazin-2-yl]sulfanylacetate is sourced from PubChem (CID 133469455), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).